Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "specialty-chemicals"

77 News Found

Nouryon launches new high-efficiency spherical silica for peptide-based pharmaceuticals
News | June 21, 2023

Nouryon launches new high-efficiency spherical silica for peptide-based pharmaceuticals

This patent-pending, high-efficiency chromatography media is used for the purification of novel peptide-based pharmaceuticals in the GLP-1 agonist class including type 2 diabetes and obesity treatments


Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
interviews | June 20, 2023

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth


Evonik partners with Safic-Alcan to boost offering of advanced food ingredients
News | May 11, 2023

Evonik partners with Safic-Alcan to boost offering of advanced food ingredients

Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt


IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to export in European market
Drug Approval | May 09, 2023

IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to export in European market

The certification issued by the EDQM verifies the compliance of pharmaceutical substances


IMCD becomes new distributor for Evonik’s medical care polymer materials
Supply Chain | May 04, 2023

IMCD becomes new distributor for Evonik’s medical care polymer materials

New agreement applies to the polymers of the Medical Care series portfolio


IOL Chemicals and Pharmaceuticals reports Q4 FY23 PAT at Rs. 65 Cr
News | May 01, 2023

IOL Chemicals and Pharmaceuticals reports Q4 FY23 PAT at Rs. 65 Cr

Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22


Aarti Drugs reports Q4 FY23 PAT at Rs.56.02 Cr
News | April 30, 2023

Aarti Drugs reports Q4 FY23 PAT at Rs.56.02 Cr

Specialty Chemicals grew 38% YoY for FY23


Calibre Chemicals takes over R&D activities of Tina Life Sciences
News | April 11, 2023

Calibre Chemicals takes over R&D activities of Tina Life Sciences

Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.


Top management changes at IOL Chemicals and Pharmaceuticals
People | April 04, 2023

Top management changes at IOL Chemicals and Pharmaceuticals

Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company


Neogen Chemicals to acquire 100% stake in BuLi Chemicals India from Livent
News | March 06, 2023

Neogen Chemicals to acquire 100% stake in BuLi Chemicals India from Livent

This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry